WCCCT Market Analysis and Reports | Japan Conference Series

Market Analysis - WCCCT 2020

According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is reckoned for $23,849.39 Million in 2017 and is estimated to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period.
 
Factors like technological advancement, a growing aging population, and people affected by diabetes, high blood pressure are favouring the market. On the other hand, increasing health expenditure, cardiovascular diseases and increasing tobacco users are supplying the market.
 
Hypertension is a chronic medical condition during which the blood pressure is elevated to an unsought level. Hypertension is a chronic disease, which means that a patient could need to require medications a day for the rest of his/her life. Thus, the demand for anti-hypertensive medication is property and can increase with a rise within the variety of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the worldwide sales worth of over USD 40 billion, according to the globe Preview 2018 report by valuate drug company.
 
Some of the key players contributing to the worldwide anti-hypertensive medication market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Takeda Pharmaceutical Company Limited.
This research report analyses this market counting on its market segments, major geographies, and current market trends. Geographies analysed under this analysis report include
North America
Asia Pacific
Europe
Rest of the World 

“6th World Congress on Cardiology and Cardiovascular Therapeutics” in Kyoto, Japan during August 24-25, 2020 around the theme ‘Highlighting Modern Techniques in Cardio and Cardiovascular Diseases. WCCCT 2020 is a premier educational event in the field of Cardiovascular Therapeutics and Cardiology that rotates between continents and is organized in collaboration with national and international Cardiac societies and associations. The World Congress on Cardiology and Cardiovascular Therapeutics is targeted to the international Cardiology, Cardiac Surgery, and Cardiovascular community as well as the other healthcare professionals involved in multidisciplinary Heart Care; thus, enabling professionals from worldwide to exchange their views on a wide variety of topics affecting heart and those suffering from heart diseases around the globe. WCCCT 2020 exists to advance the science and art of medicine and surgery related to the care of the heart. WCCCT 2020 works with many other organizations to achieve its aims of supporting patients and improving standards.